UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1107) 1107
humans (973) 973
life sciences & biomedicine (958) 958
hydrazones - therapeutic use (760) 760
pyridazines - therapeutic use (591) 591
animals (554) 554
hydrazones - pharmacology (473) 473
male (456) 456
cardiotonic agents - therapeutic use (440) 440
female (374) 374
pharmacology & pharmacy (310) 310
heart failure - drug therapy (298) 298
levosimendan (292) 292
biological and medical sciences (248) 248
cardiovascular system & cardiology (244) 244
cardiac & cardiovascular systems (235) 235
medical sciences (234) 234
hydrazones (227) 227
mice (218) 218
middle aged (209) 209
hydrazones - chemistry (200) 200
heart failure (192) 192
hydrazones - administration & dosage (189) 189
pyridazines - pharmacology (189) 189
aged (184) 184
treatment outcome (182) 182
chemistry (158) 158
physical sciences (157) 157
rats (147) 147
pyridazines - administration & dosage (142) 142
analysis (139) 139
pharmacology. drug treatments (136) 136
biochemistry & molecular biology (128) 128
cardiotonic agents - pharmacology (128) 128
vasodilator agents - therapeutic use (120) 120
heart failure - physiopathology (113) 113
general & internal medicine (112) 112
cell line, tumor (109) 109
hemodynamics - drug effects (108) 108
abridged index medicus (107) 107
hydrazones - chemical synthesis (107) 107
cardiotonic agents - administration & dosage (106) 106
cell biology (105) 105
structure-activity relationship (100) 100
adult (96) 96
heart (94) 94
infusions, intravenous (93) 93
research (91) 91
chemistry, medicinal (90) 90
dose-response relationship, drug (89) 89
time factors (89) 89
anesthesiology (86) 86
hydrazones - adverse effects (86) 86
dobutamine - therapeutic use (85) 85
science & technology - other topics (84) 84
simendan (83) 83
cancer (81) 81
chemistry, multidisciplinary (80) 80
care and treatment (79) 79
acute disease (77) 77
proteins (77) 77
disease models, animal (76) 76
health aspects (76) 76
drug therapy (75) 75
hydrazone (75) 75
medicine & public health (74) 74
apoptosis (71) 71
pyridazines - adverse effects (71) 71
cardiac patients (70) 70
critical care medicine (70) 70
randomized controlled trials as topic (70) 70
surgery (68) 68
research article (67) 67
multidisciplinary sciences (64) 64
pharmacology/toxicology (64) 64
apoptosis - drug effects (63) 63
cardiology (63) 63
drugs (63) 63
molecular structure (63) 63
pharmacology (63) 63
mortality (62) 62
myocardial contraction - drug effects (62) 62
antineoplastic agents - pharmacology (61) 61
oncology (61) 61
carbonyl cyanide m-chlorophenyl hydrazone - pharmacology (60) 60
cardiology. vascular system (59) 59
cardiotonic agents (58) 58
cardiotonic agents - adverse effects (58) 58
cell survival - drug effects (58) 58
antineoplastic agents - therapeutic use (57) 57
cardiac output, low - drug therapy (57) 57
cell line (57) 57
medicine (57) 57
cardiovascular (56) 56
prospective studies (56) 56
cardiovascular system (55) 55
double-blind method (54) 54
hydrazones - pharmacokinetics (54) 54
rats, wistar (54) 54
toxicity (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1480) 1480
German (37) 37
Spanish (23) 23
Russian (16) 16
Portuguese (12) 12
Japanese (11) 11
Italian (8) 8
Chinese (5) 5
French (5) 5
Dutch (3) 3
Turkish (2) 2
Danish (1) 1
Finnish (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Polish (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cell reports (Cambridge), ISSN 2211-1247, 05/2017, Volume 19, Issue 8, pp. 1669 - 1684
lung cancer | histone methylation | taxane-platin chemotherapy | JIB-04 | GSK-J4 | KDM | histone demethylases | demethylase inhibitors | Jumonji demethylases | drug resistance | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Lung Neoplasms - drug therapy | Transcription, Genetic - drug effects | Taxoids - pharmacology | Benzazepines - adverse effects | Humans | Aminopyridines - adverse effects | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Taxoids - therapeutic use | Hydrazones - adverse effects | Aminopyridines - therapeutic use | Carboplatin - therapeutic use | Hydrazones - therapeutic use | Jumonji Domain-Containing Histone Demethylases - antagonists & inhibitors | Bridged-Ring Compounds - pharmacology | Neoadjuvant Therapy | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Bridged-Ring Compounds - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Enzyme Inhibitors - pharmacology | Benzazepines - pharmacology | Pyrimidines - pharmacology | Enzyme Inhibitors - therapeutic use | Hydrazones - pharmacology | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Animals | Benzazepines - therapeutic use | Pyrimidines - therapeutic use | Aminopyridines - pharmacology | Pyrimidines - adverse effects | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Histones - metabolism | Carboplatin - pharmacology | Methylation | Jumonji Domain-Containing Histone Demethylases - metabolism | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article